Envestnet Asset Management Inc. acquired a new stake in shares of Amrize Ltd (NYSE:AMRZ – Free Report) during the 3rd quarter, according to its most recent disclosure with the SEC. The fund acquired 94,237 shares of the company’s stock, valued at approximately $4,573,000.
Several other institutional investors have also recently made changes to their positions in AMRZ. Norges Bank purchased a new stake in Amrize in the second quarter worth $670,915,000. Vanguard Group Inc. bought a new stake in shares of Amrize during the 2nd quarter valued at $1,065,029,000. Prudential PLC purchased a new stake in shares of Amrize in the 2nd quarter worth about $754,000. Dodge & Cox bought a new position in shares of Amrize in the 2nd quarter worth about $622,085,000. Finally, Greenland Capital Management LP purchased a new position in Amrize during the 2nd quarter valued at about $596,000.
Amrize Stock Down 2.4%
Amrize stock opened at $63.59 on Tuesday. Amrize Ltd has a 12 month low of $44.12 and a 12 month high of $65.72. The stock has a fifty day simple moving average of $56.23 and a two-hundred day simple moving average of $52.64. The company has a current ratio of 1.64, a quick ratio of 1.10 and a debt-to-equity ratio of 0.37. The firm has a market cap of $35.17 billion and a price-to-earnings ratio of 34.56.
Insider Activity
In related news, CFO Ian A. Johnston purchased 1,200 shares of Amrize stock in a transaction dated Thursday, February 19th. The stock was purchased at an average cost of $63.92 per share, for a total transaction of $76,704.00. Following the completion of the purchase, the chief financial officer directly owned 18,544 shares of the company’s stock, valued at $1,185,332.48. The trade was a 6.92% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is accessible through the SEC website.
Analyst Ratings Changes
A number of brokerages have weighed in on AMRZ. Morgan Stanley set a $61.00 price objective on shares of Amrize and gave the stock an “overweight” rating in a report on Wednesday, October 29th. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating on shares of Amrize in a research report on Monday. Oppenheimer reissued an “outperform” rating and issued a $70.00 target price (up from $64.00) on shares of Amrize in a report on Thursday. Sanford C. Bernstein reissued an “outperform” rating and issued a $70.00 target price on shares of Amrize in a research note on Thursday, December 18th. Finally, Truist Financial lifted their price target on Amrize from $60.00 to $75.00 and gave the stock a “buy” rating in a research report on Friday. One analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and six have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $63.43.
Read Our Latest Report on AMRZ
About Amrize
Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.
Featured Articles
- Five stocks we like better than Amrize
- Elon Musk already made me a “wealthy man”
- Elon’s Secret AI Partner?
- Elon Musk: This Could Turn $100 into $100,000
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- ~$1.5T SpaceX IPO: Pre-IPO Opportunity
Want to see what other hedge funds are holding AMRZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amrize Ltd (NYSE:AMRZ – Free Report).
Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.
